Provides coverage for iatrogenic fertility preservation services when caused by a medical treatment.
Summary
Bill A02686, known as the 'Fertility Protection Act', aims to amend the social services law to include coverage for fertility preservation services for individuals who may experience iatrogenic infertility due to medical treatments such as surgery, radiation, or chemotherapy. The bill defines iatrogenic infertility as any impairment of fertility resulting from medical interventions affecting reproductive organs or processes. By providing coverage for these services, the bill seeks to ensure that individuals undergoing potentially fertility-compromising treatments have access to options that may preserve their reproductive capabilities.
Impact
If enacted, this bill would expand the scope of the social services law in New York by mandating that standard fertility preservation services be covered when a medical treatment poses a risk of causing infertility. This change would directly affect health insurance providers and may lead to increased access to fertility preservation options for patients undergoing treatments that could impair their fertility. The bill aims to address a significant gap in healthcare coverage for those at risk of losing their fertility due to necessary medical procedures.
Sentiment
The sentiment surrounding Bill A02686 appears to be supportive, as it addresses a critical healthcare issue affecting many individuals facing serious medical treatments. Discussions in committee and among stakeholders have highlighted the importance of fertility preservation as a right for patients undergoing treatments that could lead to infertility. However, there may be concerns regarding the financial implications for insurance providers and the potential for increased healthcare costs.
Contention
Notable points of contention may arise from insurance companies regarding the financial burden of covering fertility preservation services. Some stakeholders may argue that the inclusion of such services could lead to increased premiums or costs for other insured individuals. Additionally, there may be differing opinions on the definition of 'standard fertility preservation services' and what specific treatments should be covered under this bill, leading to debates among healthcare providers and insurers.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause an impairment of fertility; require coverage